Lyrica
Quick Facts
Pregabalin
Date Approved
December 30, 2004
Manufacturer
Pfizer
Status
On the market
Approved Uses
Diabetic peripheral neuropathy
Seizures
Serious Side Effects
Suicide
Suicidal behavior
Death Related Topics
Neurontin
Diabetes
Defective Drugs
Diseases
Lyrica Side Effects May Be Linked to Suicide Lawsuits
Lyrica | Lawsuits, Lawyers | Side Effects: Suicide, Suicidal Behavior, Dizziness, Blurred Vision, Sleepiness, Weight Gain
Lyrica & Neurontin Association
Lyrica (Generic: Pregabalin) is prescribed to patients for the management of neuropathic pain associated with diabetic peripheral neuropathy. Lyrica, manufactured by Pfizer, received FDA approval on December 30, 2004. Seizure patients also use Lyrica. Lyrica was manufactured as a substitute medication for Neurontin. Lyrica has only been tested and prescribed to adults 18 or older. Lyrica has not been studied in children under the age of 18. Lyrica, just like Neurontin, may cause increased risk of suicide and suicidal behavior
Other Lyrica Side Effects
General side effects associated with Lyrica can include: dizziness, blurred vision, sleepiness, weight gain, swelling (edema), muscle problems, and altered perception. Weight gain is of particular concern to those with diabetes, as this can worsen their condition. Additional animal studies also found Lyrica to cause side effects in males. Lyrica lowered the fertility of some male animal subjects throughout testing. Males who received Lyrica who did reproduce had an increased risk of birth defects in their offspring.
Free Lawsuit Case Evaluation For Victims Affected By Lyrica
If you or a loved one took Lyrica and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney or call us at 1-800-LAW-INFO (1-800-529-4636).










